Results 251 to 260 of about 45,696 (262)

Mutation-Driven Evolution of Pseudomonas aeruginosa in the Presence of either Ceftazidime or Ceftazidime-Avibactam

Antimicrobial Agents and Chemotherapy, 2018
Fernando Sanz-García, Sara Hernando-Amado, JOSÉ L Martinez   +2 more
exaly  

Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program

Clinical Infectious Diseases, 2016
Florian Wagenlehner, Jack D Sobel, Paul Newell   +2 more
exaly  

Avibactam reverts the ceftazidime MIC90 of European Gram-negative bacterial clinical isolates to the epidemiological cut-off value

Journal of Chemotherapy, 2014
Gregory G Stone, Helio S Sader, Ronald N Jones   +2 more
exaly  

A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalised adults in Asia

International Journal of Antimicrobial Agents, 2017
Xinyu Qin, Min Ja Kim, Dung Anh Nguyen
exaly  

Resistance to Ceftazidime-Avibactam Is Due to Transposition of KPC in a Porin-Deficient Strain of Klebsiella pneumoniae with Increased Efflux Activity

Antimicrobial Agents and Chemotherapy, 2017
Peera Hemarajata, Dongxu Sun, Ruslan Tsivkovski   +2 more
exaly  

Revisiting REVISIT: The Case for Ceftazidime/Avibactam Plus Aztreonam

Clinical Infectious Diseases
Pranita D Tamma, Thomas P Lodise, Maria F Mojica, Federico Perez, Robert A Bonomo   +4 more
openaire   +2 more sources

Resistance to Ceftazidime-Avibactam in Klebsiella pneumoniae Due to Porin Mutations and the Increased Expression of KPC-3

Antimicrobial Agents and Chemotherapy, 2017
Romney M Humphries, Peera Hemarajata
exaly  

Impaired Inhibition by Avibactam and Resistance to the Ceftazidime-Avibactam Combination Due to the D 179 Y Substitution in the KPC-2 β-Lactamase

Antimicrobial Agents and Chemotherapy, 2017
Fabrice Compain, Michel Arthur
exaly  

Ceftazidime–Avibactam Sodium

openaire   +1 more source

Clinical impact of ceftazidime/avibactam on the treatment of suspected or proven infections in a large cohort of patients with haematological malignancies: a multicentre observational real-world study.

Journal of Antimicrobial Chemotherapy
M. Tumbarello, G. Giuliano, Marianna Criscuolo, M. D. del Principe, C. Papayannidis, N. Fracchiolla, M. Dargenio, Mariagiovanna Cefalo, G. Nadali, A. Candoni, C. Buquicchio, Francesco Marchesi, Marco Picardi, Federica Lessi, Monica Piedimonte, L. Prezioso, M. Piccini, C. Cattaneo, A. Busca, Sara Brunetti, E. Buzzatti, A. Dedola, M. Sciumè, N. Di Renzo, L. Cesini, Alessandra Vatteroni, F. Raffaelli, L. Pagano   +27 more
semanticscholar   +1 more source